TIAA CREF Investment Management’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $2.69M | Sell |
1,686
-43
| -2% | -$68.6K | ﹤0.01% | 1828 |
|
|
2018
Q4 | $3.23M | Sell |
1,729
-122
| -7% | -$228K | ﹤0.01% | 1654 |
|
|
2018
Q3 | $4.36M | Buy |
1,851
+418
| +29% | +$985K | ﹤0.01% | 1648 |
|
|
2018
Q2 | $4.94M | Buy |
1,433
+288
| +25% | +$992K | ﹤0.01% | 1606 |
|
|
2018
Q1 | $3.25M | Buy |
1,145
+24
| +2% | +$68.1K | ﹤0.01% | 1835 |
|
|
2017
Q4 | $2.88M | Sell |
1,121
-601
| -35% | -$1.55M | ﹤0.01% | 1936 |
|
|
2017
Q3 | $4.89M | Sell |
1,722
-131
| -7% | -$372K | ﹤0.01% | 1640 |
|
|
2017
Q2 | $4.38M | Buy |
1,853
+651
| +54% | +$1.54M | ﹤0.01% | 1679 |
|
|
2017
Q1 | $3.03M | Sell |
1,202
-65
| -5% | -$164K | ﹤0.01% | 1894 |
|
|
2016
Q4 | $2.86M | Sell |
1,267
-64
| -5% | -$144K | ﹤0.01% | 1981 |
|
|
2016
Q3 | $3.34K | Sell |
1,331
-112
| -8% | -$281 | ﹤0.01% | 1866 |
|
|
2016
Q2 | $4.42M | Buy |
1,443
+68
| +5% | +$208K | ﹤0.01% | 1630 |
|
|
2016
Q1 | $4.36M | Sell |
1,375
-35
| -2% | -$111K | ﹤0.01% | 1595 |
|
|
2015
Q4 | $7.24M | Sell |
1,410
-38
| -3% | -$195K | 0.01% | 1291 |
|
|
2015
Q3 | $4.61M | Sell |
1,448
-152
| -10% | -$483K | ﹤0.01% | 1586 |
|
|
2015
Q2 | $6.4M | Sell |
1,600
-170
| -10% | -$680K | ﹤0.01% | 1492 |
|
|
2015
Q1 | $7.07M | Sell |
1,770
-28
| -2% | -$112K | ﹤0.01% | 1391 |
|
|
2014
Q4 | $8.82M | Sell |
1,798
-25
| -1% | -$123K | 0.01% | 1203 |
|
|
2014
Q3 | $7.41M | Sell |
1,823
-28
| -2% | -$114K | 0.01% | 1315 |
|
|
2014
Q2 | $7.49M | Buy |
1,851
+46
| +3% | +$186K | 0.01% | 1383 |
|
|
2014
Q1 | $8.21M | Sell |
1,805
-32
| -2% | -$146K | 0.01% | 1257 |
|
|
2013
Q4 | $6.44M | Sell |
1,837
-235
| -11% | -$824K | ﹤0.01% | 1448 |
|
|
2013
Q3 | $8.52M | Sell |
2,072
-31
| -1% | -$128K | 0.01% | 1195 |
|
|
2013
Q2 | $8.32M | Buy |
+2,103
| New | +$8.32M | 0.01% | 1163 |
|